
Vice-Chancellor's Open Lecture: Professor Edvard Moser

Campus Life 2023

Open Day 2023

Amathuba (powered by Brightspace)



Igniting agency for a just and inclusive society built on health equity.

Amathuba (powered by Brightspace)

Load shedding on FHS campus for the next few days

Need support?
Latest Faculty Highlights
Health Sciences News
Health Sciences Events
Responsible Conduct of Research (RCR) Training Series
Health Sciences Notice board
Date | Title Sort descending | Description | Type | File(s) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | Advanced Computing Committee (ACC) Research Equipment Call 2023 - Faculty-prioritised Research Computer Grants | The purpose of this grant is to provide funding for strategic research related computer equipment and software items (including implementation support e.g., specialised computing services) that are not covered in the conventional way by Faculty IT Equipment Committees
Deadline for submission to Faculty Computing/IT Committees: 31 May 2023
For more information please view the Grant Call document.
|
Projects/initiatives | ||||||||||||||||||||||
- | Announcement of NRF One Call for Proposals 2023 / 2024 | Dear UCT Researchers,
The NRF has announced the opening of NRF One call for proposal applications. Please see the attached MS Word list for the NRF calls that are currently open, the internal deadlines and contact person per funding programme.
Please take note of the following:
Attachments:
It is recommended that researchers check the current funding page regularly for up to date information about open funding calls- https://www.uct.ac.za/research-support-hub/funding-contracts/current-funding-opportunities. |
Projects/initiatives | ||||||||||||||||||||||
- | CANSA Research Type A Funding Call 2023 | The Cancer Association of South Africa (CANSA) has a Research Type A Funding opportunity available on a range of cancer control determinants, including those with a focus on public health, clinical and basic sciences. Projects will be funded with up to R1 million per year for three years.
Funder Letter of Interest Deadline: 31 March 2023 Invitations for submission of full proposals will be communicated by CANSA. Further detail for this opportunity can be found here.
Please complete this FHS intention-to-submit form by 1 March 2023 if you intend applying for this call. Please note that completion of this form is for the purposes of internal support and tracking, it is not linked to funder application processes and does not commit you to applying to this opportunity. |
Projects/initiatives | ||||||||||||||||||||||
- | Funding Opportunity Announcement - Cancer Grand Challenges | The Cancer Grand Challenges works with the global research community and people affected by cancer to identify the toughest challenges in cancer research, then dares interdisciplinary, world-class teams to take them on. Cancer Grand Challenges are intended to transform cancer research. This funding opportunity seeks applications that reflect this ambition. Therefore, proposals need to be bold, innovative solutions to the challenges below, and should include evidence that applicants have actively sought out new, perhaps unusual, collaborations, that will bring fresh thinking to these problems. Cancer Grand Challenges awards are not intended to fund research that would be fundable by other response-mode schemes and initiatives.
Award details: International teams are invited to apply for up to $25m in funding. Deadlines:
For more information, click here. |
Projects/initiatives | ||||||||||||||||||||||
- | Funding Opportunity Announcement - NIH: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics | The National Institutes of Health (NIH) seeks applications for Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional; PAR-20-300 and R21 Clinical Trial Optional; PAR-23-131).
The purpose of this funding opportunity is to support translational and clinical research to improve safe and effective precision therapeutics for pregnant and lactating persons, fetuses, neonates, and children (including those with disabilities) by: 1. Advancing precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact. 2. Enhancing the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation. 3. Discovering and developing novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating persons, neonates, and children.
Award details:
Deadlines:
For more information, click here. |
Projects/initiatives | ||||||||||||||||||||||
- | Funding Opportunity Announcement: VinFuture Prize | The VinFuture Prize Council is a global and diverse team of distinguished individuals from academia, research, and industry, globally renowned for their achievements and contributions in advancing human progress in the fields of science, technology, and industry. The vision for the VinFuture Prize is to catalyse meaningful change in people’s everyday lives through tangible and highly scalable improvements in areas such as productivity, prosperity, connectivity, health, safety, environment, sustainability, as well as their overall happiness regardless of socioeconomic status. VinFuture Prize recognizes fundamental advances in science and engineering that align with the 17 Sustainable Development Goals (SDGs) of the United Nations, including eradicating poverty and hunger, enhancing health and quality of life, promoting access to quality education, clean water, and renewable energy, reducing inequality, addressing climate change etc.
Nomination process:
Award details:
Please adhere to the following deadlines: The deadline for 2023 nomination submission is Monday, May 15 at 9am
For more information, click here. |
Projects/initiatives |